Shunya Mashiko
Research Subjects
Shunya Mashiko has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Catherine Maari
Innovaderm Research, Montreal, Canada
2 shared publications - Marika Sarfati
Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) Montréal Canada
2 shared publications - Robert Bissonnette
Innovaderm Research, Montreal, Canada
2 shared publications - Akimichi Morita
Department of Geriatric and Environmental Dermatology Nagoya City University Graduate School of Medical Sciences Nagoya Japan
1 shared publication - Andrew Blauvelt
Oregon Medical Research Center, Portland, USA
1 shared publication Aya Yamamoto
Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
1 shared publication
Latest Publications
- Open Access
- 8 November 2025
- Published by Elsevier in JID Innovations
- Vol. 6 (2) , 100433
Assessing T-Cell Profile Shifts through IL-23 Inhibition by Guselkumab on Psoriasis
- 8 November 2025
- Published by Elsevier in JID Innovations
- Vol. 6 (2) , 100433
Open AccessAssessing T-Cell Profile Shifts through IL-23 Inhibition by Guselkumab on Psoriasis
- Open Access
- 12 May 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (19) , eade8872
Broad responses to chemical adducts shape the natural antibody repertoire in early infancy
Natural antibodies are an integral part of innate humoral immunity yet their development and polyreactive nature are still enigmatic. Here, we show that characteristic monoclonal natural antibodies recognize common chemical moieties or adducts, supporting the view that polyreactive antibodies may often correspond to anti-adduct antibodies. We next examined the development of immunoglobulin M (IgM) and IgG to 81 ubiquitous adducts from birth to old age. Newborn IgM only reacted to a limited number of consensus determinants. This highly restricted neonatal repertoire abruptly diversified around 6 months of age through the development of antibodies to environmental antigens and age-driven epigenetic modifications. In contrast, the IgG repertoire was diverse across the entire life span. Our studies reveal an unrecognized component of humoral immunity directed to common adducts. These findings set the ground for further investigations into the role of anti-adduct B cell responses in homeostatic functions and pathological conditions.
- 12 May 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (19) , eade8872
Open AccessBroad responses to chemical adducts shape the natural antibody repertoire in early infancy
Natural antibodies are an integral part of innate humoral immunity yet their development and polyreactive nature are still enigmatic. Here, we show that characteristic monoclonal natural antibodies recognize common chemical moieties or adducts, supporting the view that polyreactive antibodies may often correspond to anti-adduct antibodies. We next examined the development of immunoglobulin M (IgM) and IgG to 81 ubiquitous adducts from birth to old age. Newborn IgM only reacted to a limited number of consensus determinants. This highly restricted neonatal repertoire abruptly diversified around 6 months of age through the development of antibodies to environmental antigens and age-driven epigenetic modifications. In contrast, the IgG repertoire was diverse across the entire life span. Our studies reveal an unrecognized component of humoral immunity directed to common adducts. These findings set the ground for further investigations into the role of anti-adduct B cell responses in homeostatic functions and pathological conditions.
- Top Cited Papers
- 1 July 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (7) , 1707-1718.e9
Differential Changes in Inflammatory Mononuclear Phagocyte and T-Cell Profiles within Psoriatic Skin during Treatment with Guselkumab vs. Secukinumab
- 1 July 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (7) , 1707-1718.e9
Top Cited PapersDifferential Changes in Inflammatory Mononuclear Phagocyte and T-Cell Profiles within Psoriatic Skin during Treatment with Guselkumab vs. Secukinumab
- 1 May 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (5) , 1015-1025.e4
Persistence of Inflammatory Phenotype in Residual Psoriatic Plaques in Patients on Effective Biologic Therapy
- 1 May 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (5) , 1015-1025.e4
Persistence of Inflammatory Phenotype in Residual Psoriatic Plaques in Patients on Effective Biologic Therapy